2024-09-18 - Analysis Report
##  ABBV Stock Analysis Report

**Company Overview:** AbbVie Inc. (ABBV) is a global biopharmaceutical company that develops, manufactures, and commercializes a portfolio of innovative medicines across various therapeutic areas, including immunology, oncology, neuroscience, and eye care.

**Performance Analysis:**

**1. Performance vs. S&P 500:**

* **Cumulative Return:** ABBV (105.21%) outperformed the S&P 500 (VOO) (89.02%) over the analyzed period.
* **Performance Gap:** The current performance gap between ABBV and VOO is 16.19%, indicating ABBV's superior performance. 
* **Relative Divergence:**  The current relative divergence of 64.93% signifies that ABBV's performance lies at the 64.93rd percentile of its historical performance range compared to VOO.

**2. Recent Price Movement:**

* **Closing Price:** $195.73
* **Moving Averages:**
    * **5-Day MA:** $195.58
    * **20-Day MA:** $195.95
    * **60-Day MA:** $183.90

**3. Technical Indicators:**

* **RSI:** 46.3 - The RSI is currently at 46.3, indicating a neutral market sentiment for ABBV, neither overly bullish nor bearish.
* **PPO:** -0.44 - The negative PPO value suggests a slight downward momentum, potentially indicating a short-term bearish trend.
* **Delta_Previous_Relative_Divergence:** -1.21 -  This indicates a recent short-term decline in ABBV's performance compared to the S&P 500. 
* **Expected Return:** 16.59% - This indicates a potential maximum 5-year expected return based on current investment amount and market conditions.

**4. Recent Earnings Analysis:**

| Date       | EPS | Expected EPS |
|-----------|-----|--------------|
| 2024-07-25 | 2.65 | 2.57         |
| 2024-04-26 | 2.31 | 2.26         |
| 2024-02-02 | 2.79 | 2.76         |
| 2023-10-27 | 2.95 | 2.86         |
| 2023-07-27 | 2.91 | 2.79         |

* **Most Recent Earnings:** ABBV beat analysts' expectations for the most recent quarter (2024-07-25), reporting an EPS of 2.65 against an expected EPS of 2.57. This shows ABBV's continued strong performance and ability to meet or exceed market expectations.

**5. Summary:**

ABBV has demonstrated strong performance, outperforming the S&P 500 over the analyzed period.  While recent short-term technical indicators suggest a slight downward momentum, its positive performance gap and strong earnings indicate a potentially bullish outlook. 

**6. Investment Implications:**

ABBV's consistent performance, along with its positive earnings and attractive expected return, make it a potentially compelling investment opportunity for long-term investors. However, it is essential to consider individual risk tolerance, investment goals, and market volatility when making investment decisions. 
